(Q41208114)

28 September 2017

Markers of disease severity in peripheral atherosclerosis (English)

1 reference

28 September 2017

1 reference

Stringer MD

1

1 reference

PubMed ID

2226885

28 September 2017

Kakkar VV

series ordinal

2

1 reference

28 September 2017

1 October 1990

1 reference

European journal of vascular surgery

28 September 2017

1 reference

28 September 2017

4

1 reference

28 September 2017

5

1 reference

28 September 2017

513-518

1 reference

Severity of coronary atherosclerosis related to lipoprotein concentration

28 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Risk factors and the anatomic distribution of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Intermittent claudication: prevalence and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Aetiology of peripheral atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Lack of association between haemostatic variables and the presence or the extent of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Statistical methods for assessing agreement between two methods of clinical measurement

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Lipid peroxides and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Serum lipids and lipoproteins in peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Epidemiology of atherosclerotic arterial disease in the lower limbs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Update on Some Epidemiologic Features of Intermittent Claudication: The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Relation between extent of coronary artery disease and blood viscosity.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Haemostatic function and cardiovascular death: early results of a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Free-radical damage to lipids, amino acids, carbohydrates and nucleic acids determined by thiobarbituric acid reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Aspects to consider when detecting and measuring lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Plasma thiobarbituric acid reactivity: reaction conditions and the role of iron, antioxidants and lipid peroxy radicals on the quantitation of plasma lipid peroxides

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Selective microdetermination of lipid hydroperoxides

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Determination of plasma lipoperoxides by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Detection and characterization of lipid hydroperoxides at picomole levels by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Serum lipids, lipid peroxides and the care of children with high risk atherosclerotic family history

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Determination of malonaldehyde in oxidized lipids by the Hantzsch fluorometric method

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Lipid peroxide levels of serum lipoprotein fractions of diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

Inhibition of antithrombin III by lipid peroxides

1 reference

https://api.crossref.org/works/10.1016%2FS0950-821X%2805%2980794-7

7 January 2021

10.1016/S0950-821X(05)80794-7

Identifiers

DOI

1 reference

28 September 2017

1 reference

PubMed ID

2226885